Joint Fondazione Aldo Torsoli – Rome Foundation Research Award
For research, education and patient care in the area of gut-brain interactions
We are pleased to announce a joint award of the Rome Foundation with the Aldo Torsoli Foundation in the area of GI Functional Disorders. Applicants must hold a medical degree or Ph.D. and have an academic record of research, education, and patient care in the area of gut-brain interaction disorders (DGBI, formerly FGID).
Click HERE to submit the application form.
Please note that applications and self-applications both require a letter of recommendation and completion of the required online forms. To be considered for this award, the candidate must be a middle or senior level and have an academic record of research, education, and patient care in the area of intestinal brain interactions (DGBI). Applicants must have completed an MD or PhD and be currently active in DGBI research.
The recipient of the award will be selected by a joint Scientific Selection Committee composed of six members, three from each Foundation. The award will be presented during the Fondazione di Roma’s annual reception at DDW in May 2022. After the DDW, the recipient will hold a lecture on their work which will eventually be available for online streaming.
2022 Aldo Torsoli Award
Hans Törnblom, MD PhD
Associate Professor of Gastroenterology and Senior Consultant Gastroenterologist
Dept of Molecular and Clinical Medicine, Inst of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Dr Törnblom is a clinical scientist and educator in the field of disorders of gut-brain interaction (DGBI). As a physician, the management of patients with severe, incapacitating GI symptoms not responding to standard therapies is central. His research has a focus on pathophysiologic mechanisms and intervention studies in irritable bowel syndrome, functional dyspepsia, and severe gastrointestinal neuromuscular disease. He is current co-chair in the Rome V committee for Gastroduodenal Disorders and was member of the Rome Foundation Working Team report on Neuromodulators for FGIDs.
2021 Aldo Torsoli Award
Carlo Di Lorenzo, MD
Dr. Ford is a proponent of evidence-based medicine, with an interest in disorders of brain-gut interaction (DGBI). His work has informed management guidelines in both the UK and USA, and has informed treatment paradigms for several DGBI. He is the principal investigator of the ATLANTIS study in the UK, a large randomised controlled trial of amitriptyline for irritable bowel syndrome.